Lifastuzumab (Anti-SLC34A2)

Lifastuzumab (Anti-SLC34A2) is a monoclonal antibody targeting SLC34A2 (sodium phosphate 2 transporter(NaPi2b)). It has anticancer activity and can be used in research of ovarian cancer (OC).

• Supplier: Selleck Chemicals
• Product #: A3163
• Sku #: A3163-1mg